Stay updated on Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s footer has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a website release/version change rather than a change to the clinical trial study details.
    Difference
    0.0%
    Check dated 2026-04-24T06:00:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:35:15.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Small cell lung carcinoma to the conditions list and included a Genetic and Rare Diseases Information Center resource entry.
    Difference
    0.1%
    Check dated 2026-04-02T15:30:41.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added and the previous revision v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:49:14.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Revision notes updated: added Revision: v3.4.3 and removed Revision: v3.4.2. These are backend/versioning updates and do not change the study details or user-facing content on the page.
    Difference
    0.0%
    Check dated 2026-03-12T01:44:01.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2 and removes the funding/operating status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:44:46.000Z thumbnail image

Stay in the know with updates to Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Vorolanib Safety/Activity in Thoracic Tumors Clinical Trial page.